
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (09): 1109-1117.DOI: 10.12114/j.issn.1007-9572.2023.0483
Special Issue: 儿科最新文章合辑; 运动相关研究最新文章合辑; 心血管最新文章合辑; 生活方式干预相关研究最新文章合辑; 肥胖/减重最新文章合辑 ; 女性健康最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2023-07-31
Revised:2023-10-24
Published:2024-03-20
Online:2023-12-19
Contact:
XU Baichao
通讯作者:
徐百超
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0483
| 组别 | 人数 | 年龄(岁) | 身高(cm) | 体质量(kg) |
|---|---|---|---|---|
| 对照组 | 24 | 15.0±0.8 | 153.48 ± 4.34 | 68.78 ± 1.57 |
| 试验组 | 20 | 14.8±0.8 | 153.40± 5.17 | 69.05 ± 1.85 |
| t值 | 0.670 | 0.054 | -0.514 | |
| P值 | 0.509 | 0.957 | 0.610 |
Table 1 Comparison of general characteristics of female adolescents between the control group and experimental group
| 组别 | 人数 | 年龄(岁) | 身高(cm) | 体质量(kg) |
|---|---|---|---|---|
| 对照组 | 24 | 15.0±0.8 | 153.48 ± 4.34 | 68.78 ± 1.57 |
| 试验组 | 20 | 14.8±0.8 | 153.40± 5.17 | 69.05 ± 1.85 |
| t值 | 0.670 | 0.054 | -0.514 | |
| P值 | 0.509 | 0.957 | 0.610 |
| 组别 | 人数 | BFR(%) | WC(cm) | BMI(kg/m2) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 34.07±0.85 | 34.16±0.72 | -1.325 | 0.164 | 87.0±1.0 | 87.0±1.8 | -1.269 | 0.208 | 29.0±1.3 | 29.3±1.8 | -1.481 | 0.153 |
| 试验组 | 20 | 33.24±0.26 | 30.52±1.01 | 13.377 | <0.001 | 87.0±0.9 | 85.1±0.8 | 6.275 | <0.001 | 29.0±1.1 | 28.8±2.1 | 0.467 | 0.646 |
| t值 | 2.160 | 14.904 | -1.956 | 9.462 | 0.039 | 0.056 | |||||||
| P值 | 0.150 | <0.001 | 0.118 | <0.001 | 0.970 | 0.842 | |||||||
Table 2 Comparison of BFR,WC and BMI between the control group and experimental group
| 组别 | 人数 | BFR(%) | WC(cm) | BMI(kg/m2) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 34.07±0.85 | 34.16±0.72 | -1.325 | 0.164 | 87.0±1.0 | 87.0±1.8 | -1.269 | 0.208 | 29.0±1.3 | 29.3±1.8 | -1.481 | 0.153 |
| 试验组 | 20 | 33.24±0.26 | 30.52±1.01 | 13.377 | <0.001 | 87.0±0.9 | 85.1±0.8 | 6.275 | <0.001 | 29.0±1.1 | 28.8±2.1 | 0.467 | 0.646 |
| t值 | 2.160 | 14.904 | -1.956 | 9.462 | 0.039 | 0.056 | |||||||
| P值 | 0.150 | <0.001 | 0.118 | <0.001 | 0.970 | 0.842 | |||||||
| 组别 | 人数 | SBP | DBP | PP | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 132±3 | 132±3 | -1.106 | 0.312 | 82±1 | 82±1 | -1.40 | 0.890 | 50±4 | 50±3 | -1.031 | 0.142 |
| 试验组 | 20 | 133±3 | 127±1 | 7.651 | <0.001 | 82±1 | 81±1 | 4.053 | 0.001 | 51±3 | 46±1 | 6.795 | <0.001 |
| t值 | -7.430 | 9.179 | 0.807 | 4.953 | -0.923 | 1.893 | |||||||
| P值 | 0.462 | <0.001 | 0.424 | <0.001 | 0.361 | 0.065 | |||||||
Table 3 Comparison of blood pressure of female adolescents between the control group and experimental group
| 组别 | 人数 | SBP | DBP | PP | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 132±3 | 132±3 | -1.106 | 0.312 | 82±1 | 82±1 | -1.40 | 0.890 | 50±4 | 50±3 | -1.031 | 0.142 |
| 试验组 | 20 | 133±3 | 127±1 | 7.651 | <0.001 | 82±1 | 81±1 | 4.053 | 0.001 | 51±3 | 46±1 | 6.795 | <0.001 |
| t值 | -7.430 | 9.179 | 0.807 | 4.953 | -0.923 | 1.893 | |||||||
| P值 | 0.462 | <0.001 | 0.424 | <0.001 | 0.361 | 0.065 | |||||||
| 组别 | 人数 | FPG(μU/mL) | 胰岛素(mg/dL) | HOMA-IR | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 89.07±2.87 | 88.87±6.29 | 0.282 | 0.781 | 14.79±1.31 | 14.58±1.08 | 1.351 | 0.190 | 3.25±0.31 | 3.20±0.33 | 1.181 | 0.250 |
| 试验组 | 20 | 90.24±0.79 | 87.58±1.27 | 8.367 | <0.001 | 13.54±0.84 | 9.82±0.89 | 12.898 | <0.001 | 3.02±0.19 | 2.12±0.20 | 14.271 | <0.001 |
| t值 | -1.758 | 9.326 | 2.166 | 15.641 | 0.896 | 12.828 | |||||||
| P值 | 0.086 | <0.001 | 0.160 | <0.001 | 0.372 | <0.001 | |||||||
Table 4 Comparison of FPG,insulin and HOMA-IR of female adolescents between the control group and experimental group
| 组别 | 人数 | FPG(μU/mL) | 胰岛素(mg/dL) | HOMA-IR | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 89.07±2.87 | 88.87±6.29 | 0.282 | 0.781 | 14.79±1.31 | 14.58±1.08 | 1.351 | 0.190 | 3.25±0.31 | 3.20±0.33 | 1.181 | 0.250 |
| 试验组 | 20 | 90.24±0.79 | 87.58±1.27 | 8.367 | <0.001 | 13.54±0.84 | 9.82±0.89 | 12.898 | <0.001 | 3.02±0.19 | 2.12±0.20 | 14.271 | <0.001 |
| t值 | -1.758 | 9.326 | 2.166 | 15.641 | 0.896 | 12.828 | |||||||
| P值 | 0.086 | <0.001 | 0.160 | <0.001 | 0.372 | <0.001 | |||||||
| 组别 | 人数 | Laps(次) | MAS(km/h) | VO2max(mL·kg-1·min-1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 25.00±0.97 | 24.67±1.08 | 1.261 | 0.231 | 9.52±0.12 | 9.55±0.14 | -1.239 | 0.228 | 37.03±1.09 | 37.14±0.77 | -0.684 | 0.501 |
| 试验组 | 20 | 21.90±1.16 | 28.04±0.65 | -23.915 | <0.001 | 9.56±0.69 | 9.87±0.49 | -21.430 | <0.001 | 36.88±0.67 | 39.00±0.44 | -11.832 | <0.001 |
| t值 | 0.843 | -12.153 | -1.111 | -9.519 | 0.520 | -9.660 | |||||||
| P值 | 0.386 | <0.001 | 0.273 | <0.001 | 0.606 | <0.001 | |||||||
Table 5 Comparison of Laps,MAS and VO2max of female adolescents between the control group and experimental group
| 组别 | 人数 | Laps(次) | MAS(km/h) | VO2max(mL·kg-1·min-1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 25.00±0.97 | 24.67±1.08 | 1.261 | 0.231 | 9.52±0.12 | 9.55±0.14 | -1.239 | 0.228 | 37.03±1.09 | 37.14±0.77 | -0.684 | 0.501 |
| 试验组 | 20 | 21.90±1.16 | 28.04±0.65 | -23.915 | <0.001 | 9.56±0.69 | 9.87±0.49 | -21.430 | <0.001 | 36.88±0.67 | 39.00±0.44 | -11.832 | <0.001 |
| t值 | 0.843 | -12.153 | -1.111 | -9.519 | 0.520 | -9.660 | |||||||
| P值 | 0.386 | <0.001 | 0.273 | <0.001 | 0.606 | <0.001 | |||||||
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
张艺宏,徐峻华,何本祥. 运动机能评定理论与方法[M]. 北京:科学出版社,2018.
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [1] | LI Lan, LIU Lidi, ZHANG Peng, LI Dongze, YANG Ziyu, CHENG Yonglang, LIAO Xiaoyang, WAN Zhi. Lifestyle Intervention-based Weight Management: an Analysis of Key Highlights from the Partial Update of the 2025 NICE Guideline Overweight and Obesity Management (NG246) [J]. Chinese General Practice, 2026, 29(30): 4353-4359. |
| [2] | SHU Xinyu, YAO Mi, JUAN Juan, LI Chenglong, KANG Xin, YANG Huixia. Gestational Weight Gain and Energy Management: Composition, Relationship Exploration and Future Perspectives [J]. Chinese General Practice, 2026, 29(29): 4295-4302. |
| [3] | ZHANG Han, CAI Genshen, FENG Zhengwen, ZHANG Kaiyue, LIAN Dongbo, ZHANG Hua, ZHANG Jing. Evaluating the Availability of Health Services for Obesity Comorbidities under Hierarchical Diagnosis and Treatment in Beijing: a Healthcare Institution Survey Study [J]. Chinese General Practice, 2026, 29(28): 4117-4124. |
| [4] | FU Xiaoya, YANG Fei, GU Keyi, GU Handong, WANG Weiqiang. Correlation between Relative Fat Mass Index and Decreased Glomerular Filtration Rate in Patients with Cardiometabolic Comorbidities [J]. Chinese General Practice, 2026, 29(28): 4187-4192. |
| [5] | ZHANG Ying, TANG Yijun, LIU Lidi, JIANG Lihua, JIA Yu, YANG Rong, YANG Ziyu, LIAO Xiaoyang. Management of Cardiovascular Metabolic Risks in Obese Children and Adolescents in China: Based on the 2024 Italian Society of Pediatric Endocrinology and Diabetes Position Paper on Cardiometabolic Risk in Children and Adolescents with Obesity [J]. Chinese General Practice, 2026, 29(27): 3879-3887. |
| [6] | Expert Group on Guidelines for the Assessment, Treatment, and Prevention of Childhood Obesity in China, Professional Committee on Obesity Control in Women and Children, China Maternal and Child Health Research Association. Guidelines for the Assessment, Treatment, and Prevention of Childhood Obesity in China (Second Edition) [J]. Chinese General Practice, 2026, 29(23): 3233-3252. |
| [7] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [8] | ZHANG Ke, ZENG Xianchang, ZOLZAYA Enkhzaya, ZHU Yelin, HUANG Yiwen, LIU Zhenxiu, TAO Feng. Effect of Xiere Xingpi Yin on Eating Behaviors and Weight-related Outcomes in Patients with Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(20): 2759-2765. |
| [9] | WU Zhen, XI Yaqi, HU Linlin. Characteristics of Policy Instrument Selection and Combination for Weight Management in China: a Content Analysis of National Policy Documents (2016-2025) [J]. Chinese General Practice, 2026, 29(20): 2766-2774. |
| [10] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [11] | CHEN Xiangyang, HUANG Hongmei, LI Sheyu. Prevention and Management of Adult Obesity: Progress and Trends from Six Keywords in 2025 [J]. Chinese General Practice, 2026, 29(20): 2753-2758. |
| [12] | TANG Lijuan, QI Qi, ZHANG Fan, GAO Yifu, CAO Yajing, YUE Fujuan, GAO Jinchai, LIU Xiaoli. Characterisation of the Prevalence of Overweight/Obesity among Residents Aged 18-44 Years in Hebei Province in 2013 and 2020 [J]. Chinese General Practice, 2026, 29(19): 2695-2704. |
| [13] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [14] | LI Simin, ZHANG Tingting, WANG Kunbo, YANG Jianzhou, PING Weiwei. Effects of Exercise Dosage on Elderly Patients with Sarcopenia: a Meta-analysis [J]. Chinese General Practice, 2026, 29(17): 2400-2409. |
| [15] | Chinese Nutrition Society Obesity Prevention and Control Branch. Chinese Guidelines for Behavioral and Lifestyle Interventions for Obesity [J]. Chinese General Practice, 2026, 29(16): 2113-2139. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||